From professional translators, enterprises, web pages and freely available translation repositories.
lumiracoxib
lumiracoxib
Last Update: 2014-12-09
Usage Frequency: 19
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
lumiracoxib (product)
lumiracoxib (producto)
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
lumiracoxib can be used with low-dose aspirin.
lumiracoxib puede utilizarse con dosis bajas de aspirina.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
lumiracoxib is excreted in the milk of lactating rats.
lumiracoxib se excreta en la leche de ratas lactantes.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
omeprazole had no effect on the pharmacokinetics of lumiracoxib.
omeprazol no tuvo efectos en la farmacocinética de lumiracoxib.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
absorption lumiracoxib is rapidly absorbed following oral administration.
absorción lumiracoxib se absorbe rápidamente tras la administración oral.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
the oxidative metabolism of lumiracoxib is mainly cyp2c9 mediated.
el metabolismo oxidativo de lumiracoxib está mediado principalmente por cyp2c9.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
each 100 mg film-coated tablet contains 100 mg lumiracoxib.
cada comprimido recubierto con película de 100 mg contiene 100 mg de lumiracoxib.
Last Update: 2012-04-10
Usage Frequency: 9
Quality:
the mean plasma half-life of lumiracoxib is approximately 4 hours.
la vida media plasmática de lumiracoxib es de aproximadamente 4 horas.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
-recommended follow up measures to further investigate the safety of lumiracoxib.
-recomienda medidas de seguimiento para continuar investigando la seguridad de lumiracoxib.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
in preclinical studies, lumiracoxib has been demonstrated to be neither mutagenic nor carcinogenic.
en los estudios preclínicos, lumiracoxib ha demostrado que no es mutagénico ni carcinogénico.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
for all medicinal products containing celecoxib, etoricoxib, lumiracoxib, parecoxib, and valdecoxib
comitÉ de medicamentos de uso humano (chmp) dictamen de conformidad con lo dispuesto en el artÍculo 31 para todos los medicamentos que contienen celecoxib, etoricoxib, lumiracoxib, parecoxib, y valdecoxib
Last Update: 2011-10-23
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
mean exposure to the active 4'-hydroxy-lumiracoxib metabolite was largely unaffected.
la exposición media al metabolito activo 4’ -hidroxi-lumiracoxib no quedó prácticamente afectada.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
4'-hydroxy-lumiracoxib, 5-carboxy-lumiracoxib and 4'-hydroxy-5-carboxy-lumiracoxib.
4'-hidroxi-lumiracoxib, 5-carboxi-lumiracoxib y 4-hidroxi-5-carboxi-lumiracoxib.
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
